Abingworth

Abingworth as of Dec. 31, 2016

Portfolio Holdings for Abingworth

Abingworth holds 17 positions in its portfolio as reported in the December 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Crispr Therapeutics (CRSP) 43.7 $52M 2.6M 20.00
Paratek Pharmaceuticals 16.8 $20M 1.3M 15.35
Sientra 15.7 $19M 2.2M 8.50
Novan 4.5 $5.4M 200k 26.88
Chiasma 3.3 $4.0M 2.1M 1.90
Proteon Therapeutics 3.0 $3.6M 2.0M 1.80
Cymabay Therapeutics (CBAY) 2.3 $2.7M 1.6M 1.70
Dermira 1.8 $2.1M 70k 30.31
Lombard Med (EVARF) 1.7 $2.0M 3.5M 0.59
Cellectis S A (CLLS) 1.4 $1.7M 100k 16.91
Histogenics Corp Cmn 1.2 $1.4M 889k 1.62
Senseonics Hldgs (SENS) 1.2 $1.4M 517k 2.66
Immune Design 0.9 $1.1M 197k 5.45
Adaptimmune Therapeutics (ADAP) 0.8 $1.0M 250k 4.01
Dicerna Pharmaceuticals 0.8 $973k 338k 2.88
Anthera Pharmaceutcls 0.5 $560k 862k 0.65
Innocoll 0.3 $360k 537k 0.67